Sensei Biotherapeutics Inc (SNSE)
0.6467
+0.04
(+6.54%)
USD |
NASDAQ |
Jun 21, 16:00
0.62
-0.03
(-4.13%)
After-Hours: 20:00
Sensei Biotherapeutics Total Return Level: 0.6467 for June 21, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 21, 2024 | 0.6467 |
June 20, 2024 | 0.607 |
June 18, 2024 | 0.592 |
June 17, 2024 | 0.6044 |
June 14, 2024 | 0.6383 |
June 13, 2024 | 0.658 |
June 12, 2024 | 0.675 |
June 11, 2024 | 0.709 |
June 10, 2024 | 0.6698 |
June 07, 2024 | 0.6503 |
June 06, 2024 | 0.6625 |
June 05, 2024 | 0.7038 |
June 04, 2024 | 0.6733 |
June 03, 2024 | 0.7281 |
May 31, 2024 | 0.7396 |
May 30, 2024 | 0.755 |
May 29, 2024 | 0.849 |
May 28, 2024 | 0.83 |
May 24, 2024 | 0.79 |
May 23, 2024 | 1.45 |
May 22, 2024 | 1.36 |
May 21, 2024 | 1.40 |
May 20, 2024 | 1.50 |
May 17, 2024 | 1.53 |
May 16, 2024 | 1.59 |
Date | Value |
---|---|
May 15, 2024 | 1.49 |
May 14, 2024 | 1.51 |
May 13, 2024 | 1.57 |
May 10, 2024 | 1.51 |
May 09, 2024 | 1.57 |
May 08, 2024 | 1.84 |
May 07, 2024 | 1.81 |
May 06, 2024 | 1.84 |
May 03, 2024 | 1.79 |
May 02, 2024 | 1.65 |
May 01, 2024 | 1.26 |
April 30, 2024 | 1.020 |
April 29, 2024 | 1.02 |
April 26, 2024 | 1.02 |
April 25, 2024 | 1.000 |
April 24, 2024 | 0.9917 |
April 23, 2024 | 0.9977 |
April 22, 2024 | 0.9309 |
April 19, 2024 | 0.97 |
April 18, 2024 | 0.9829 |
April 17, 2024 | 1.00 |
April 16, 2024 | 0.9881 |
April 15, 2024 | 1.005 |
April 12, 2024 | 1.05 |
April 11, 2024 | 1.09 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.5301
Minimum
Oct 30 2023
22.75
Maximum
Feb 08 2021
4.095
Average
1.61
Median
May 02 2022
Total Return Level Benchmarks
Regeneron Pharmaceuticals Inc | 1053.30 |
Oragenics Inc | 1.44 |
Rezolute Inc | 3.943 |
GT Biopharma Inc | 2.85 |
IGM Biosciences Inc | 7.27 |